This monthly feature focuses on various tranches and rounds of funding for healthcare ventures, startups and funds. Links indicate target companies and lead investors.
Target | Investors | Amount | Date |
---|---|---|---|
Entasis Therapeutics | Clarus Funds, Frazier Healthcare Partners, Novo A/S, Eventide Funds, Pivotal bioVenture, Sofinnova Ventures and TPG Biotech | $31.9 million Series B-1 | September 5, 2017 |
Synergy Pharmaceuticals | CRG LP | $300 million debt funding | September 5, 2017 |
Mid-Atlantic Dental Partners | S.C. Goldman and Company, LLC | $12.5 million | September 6, 2017 |
WuXi NextCODE | Sequoia Capital and Temasek, Yunfeng Capital and 3W Partners | $240 million Series B | September 7, 2017 |
Talkspace | Qumra Capital and Norwest Venture Partners, Spark Capital, SoftBank, Compound Ventures and FirstTime. | $31 million Series C | September 7, 2017 |
Cheetah Medical | MVM Life Science Partners, Springfield Investment Management, Fletcher Spaght Ventures, HighCape Partners and Robert Bosch Venture Capital | $11.76 million Series C | September 12, 2017 |
Prellis Biologics | True Ventures | $1.8 million seed round | September 13, 2107 |
Carrot Fertility | SoftTech VC with Maven Ventures, Percursor Ventures, Sound Ventures, Sherpa Ventures, Core VC, Founders Fund, Y Combinator and angel investors | $3.6 million seed round | September 14, 2017 |
Sonendo Inc. | General Atlantic with Fjord Ventures, OrbiMed Advisors, Meritech Capital Partners, CVF LLC and NeoMed | $50 million | September 18, 2017 |
98point6 | Unidentified | $19.5 million Series B | September 19, 2017 |
Landos Biopharma | Perceptive Advisors | $10 million Series A | September 21, 2017 |
Fusion Pharmaceuticals | Adams Street Partners with seroba Life Sciences and Varian Medical Systems Inc. | $21 million Series A extension | September 25, 2017 |
SpringWorks Therapeutics | Bain Capital Life Sciences, Bain Capital Double Impact, OrbiMed, Pfizer and LifeArc | $103 million Series A | September 25, 2017 |
Engage Therapeutics | TPG Biotech withAdage Capital Management and Lumira Capital | $23 million Series A | September 27, 2017 |